The limited effect of omega-3 polyunsaturated fatty acids on cardiovascular risk in patients with impaired glucose metabolism: a meta-analysis.

[1]  M. Roncaglioni,et al.  n-3 fatty acids in patients with multiple cardiovascular risk factors. , 2013, The New England journal of medicine.

[2]  E. Ntzani,et al.  Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. , 2012, JAMA.

[3]  S. Yusuf,et al.  n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. , 2012, The New England journal of medicine.

[4]  H. Seo,et al.  Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. , 2012, Archives of internal medicine.

[5]  J. Geleijnse,et al.  n-3 Fatty Acids, Ventricular Arrhythmia–Related Events, and Fatal Myocardial Infarction in Postmyocardial Infarction Patients With Diabetes , 2011, Diabetes Care.

[6]  P. Galan,et al.  Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial , 2010, BMJ : British Medical Journal.

[7]  G. Steinbeck,et al.  OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial Infarction , 2010, Circulation.

[8]  J. Geleijnse,et al.  n-3 fatty acids and cardiovascular events after myocardial infarction. , 2010, The New England journal of medicine.

[9]  M. Eshraghian,et al.  The efficacy of omega-3 fatty acid supplementation on plasma homocysteine and malondialdehyde levels of type 2 diabetic patients. , 2010, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[10]  R. Tamler,et al.  Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus. , 2010, The American journal of clinical nutrition.

[11]  Chun-Ka Wong,et al.  Fish‐oil supplement has neutral effects on vascular and metabolic function but improves renal function in patients with Type 2 diabetes mellitus , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[12]  Y. Matsuzawa,et al.  Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS). , 2009, Atherosclerosis.

[13]  L. Tavazzi,et al.  Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial , 2009, Expert review of cardiovascular therapy.

[14]  Douglas G. Altman,et al.  Effect Measures for Meta‒Analysis of Trials with Binary Outcomes , 2008 .

[15]  S. Lydersen,et al.  Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes , 2008, European Journal of Clinical Nutrition.

[16]  K. Clément,et al.  Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. , 2007, The American journal of clinical nutrition.

[17]  L. Tavazzi,et al.  Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial , 2007, Journal of cardiovascular medicine.

[18]  Y. Matsuzawa,et al.  Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis , 2007, The Lancet.

[19]  S. Lydersen,et al.  Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. , 2006, The American journal of clinical nutrition.

[20]  D. Mozaffarian,et al.  Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. , 2004, The American journal of clinical nutrition.

[21]  J. Manson,et al.  Fish and Long-Chain &ohgr;-3 Fatty Acid Intake and Risk of Coronary Heart Disease and Total Mortality in Diabetic Women , 2003, Circulation.

[22]  G. Watts,et al.  Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. , 2002, The American journal of clinical nutrition.

[23]  P. Marckmann,et al.  Effect of fish oil versus corn oil supplementation on LDL and HDL subclasses in type 2 diabetic patients. , 2002, Diabetes care.

[24]  A. Simopoulos,et al.  The importance of the ratio of omega-6/omega-3 essential fatty acids. , 2002, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[25]  GISSI-Prevenzione Investigators,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.

[26]  M. Franzosi,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. , 1999 .

[27]  J. Oppert,et al.  Moderate Intake of n-3 Fatty Acids for 2 Months Has No Detrimental Effect on Glucose Metabolism and Could Ameliorate the Lipid Profile in Type 2 Diabetic Men: Results of a controlled study , 1998, Diabetes Care.

[28]  C. Sirtori,et al.  One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations. , 1998, Atherosclerosis.

[29]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[30]  M. Tramèr,et al.  Impact of covert duplicate publication on meta-analysis: a case study , 1997, BMJ.

[31]  C. Sirtori,et al.  N-3 fatty acids do not lead to an increased diabetic risk in patients with hyperlipidemia and abnormal glucose tolerance. Italian Fish Oil Multicenter Study. , 1997, The American journal of clinical nutrition.

[32]  G. D. Johnston,et al.  Effect of dietary fish oil supplementation on peroxidation of serum lipids in patients with non-insulin dependent diabetes mellitus. , 1996, Atherosclerosis.

[33]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[34]  W. A. Morgan,et al.  A Comparison of Fish Oil or Corn Oil Supplements in Hyperlipidemic Subjects with NIDDM , 1995, Diabetes Care.

[35]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[36]  G. D. Johnston,et al.  Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[37]  D. Schoenfeld,et al.  Effects of a Small Quantity of ω-3 Fatty Acids on Cardiovascular Risk Factors in NIDDM: A randomized, prospective, double-blind, controlled study , 1994, Diabetes Care.

[38]  J. Sixma,et al.  Effects of Low-Dose EPA-E on Glycemic Control, Lipid Profile, Lipoprotein(a), Platelet Aggregation, Viscosity, and Platelet and Vessel Wall Interaction in NIDDM , 1993, Diabetes Care.

[39]  D. Jacobs,et al.  Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial , 1992 .

[40]  D. Jacobs,et al.  Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. , 1992, Archives of internal medicine.

[41]  J. Yudkin,et al.  Effects of Fish Oil Supplements in NIDDM Subjects: Controlled Study , 1990, Diabetes Care.

[42]  L. Monnier,et al.  Influence of Indigestible Fibers on Glucose Tolerance , 1978, Diabetes Care.

[43]  O. Green,et al.  Schmidt's Syndrome in a Child with Diabetes Mellitus , 1978, Diabetes Care.

[44]  J. Lellouch,et al.  Etude quantitative d'anticorps humains anti-insulines animales par la méthode radio-Immunologique de Berson et Yalow , 1965, Diabetologia.

[45]  R. Holman,et al.  Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial , 2008, Diabetologia.

[46]  G. D. Johnston,et al.  Dietary fish oil augments nitric oxide production or release in patients with Type 2 (non-insulin-dependent) diabetes mellitus , 2004, Diabetologia.